Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. May 28, 2014; 20(20): 6170-6179
Published online May 28, 2014. doi: 10.3748/wjg.v20.i20.6170
Published online May 28, 2014. doi: 10.3748/wjg.v20.i20.6170
Council of Europe guidelines[17]: Donors with unacceptable risk of transmission | |
Features applicable to cancer of any histological type at any time prior to donation | |
Presence of metastasis - lymphatic or distant | |
Absence of curative surgical treatment or missed follow-up (except low-grade prostate cancer under surveillance) | |
Palliative therapy for cancer | |
Non-CNS cancer at any time prior to donation | |
Breast | |
Ovary | |
Choriocarcinoma | |
Malignant melanoma, including carcinoma-in-situ | |
Sarcoma | |
Chronic Leukaemia | |
Thyroid (except capsulated papillary or minimally invasive follicular type) | |
Non-CNS cancer diagnosed during donor procurement | |
All cancers, except: | |
Renal cell cancer < 2.5-4.0 cm (pT1a), tumour free resection margin and Fuhrman grade I or II | |
Localised low grade (Gleason score ≤ 6) prostate cancer | |
Small gastrointestinal stromal tumours | |
Localised non-melanoma skin cancer | |
Cancers of the CNS | |
WHO grade IV cancers | |
WHO grade III cancers with following features: | |
Presence of ventriculo-peritoneal or ventriculo-atrial shunts | |
Craniotomy | |
Systemic chemotherapy | |
Radiotherapy | |
OPTN/UNOS guidelines[18] - intermediate or high risk of transmission | |
Intermediate risk of transmission (1%-10%) Breast cancer, stage 0 Colon cancer, stage 0 Renal cell cancer (resected, solitary): 4-7 cm, well differentiated, stage I Treated non-CNS malignancy (≥ 5 yr prior) with cure rate 90%-99% | High risk of transmission (> 10%) Breast cancer, stage > 0 Colon cancer, stage > 0 Renal cell cancer: > 7 cm or stage II-IV Choriocarcinoma Leukaemia Lymphoma Small cell cancer: lung/neuroendocrine Metastatic carcinoma Sarcoma Lung cancer: stage I-IV Any CNS tumour with ventriculo-peritoneal or ventriculo-atrial shunt, surgery (other than uncomplicated biopsy), irradiation or extra-cranial metastases CNS tumour of WHO grade III or IV Any other cancer with insufficient follow-up or probability of cure < 90% |
-
Citation: Desai R, Neuberger J. Donor transmitted and
de novo cancer after liver transplantation. World J Gastroenterol 2014; 20(20): 6170-6179 - URL: https://www.wjgnet.com/1007-9327/full/v20/i20/6170.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i20.6170